The peptidyl-prolyl isomerase Pin1 regulates granulocyte-macrophage colony-stimulating factor mRNA stability in T lymphocytes

Journal of Immunology

Volumn 177, Issue 10, 2006, Pages 6999-7006

  Esnault, Stephane ^a   Shen, Zhong Jian ^a   Whitesel, Emily ^a   Malter, James S ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHILIN; CYCLOPHILIN A; CYTOKINE; ENZYME; FK 506 BINDING PROTEIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN D; JUGLONE; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; PHYTOHEMAGGLUTININ;

ARTICLE; CD4+ T LYMPHOCYTE; CELL LYSATE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MONOCYTE; PRIORITY JOURNAL; RNA STABILITY; T LYMPHOCYTE;

EID: 33750801024     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.10.6999     Document Type: Article

References (58)

1. Halloran, P. F. 2004. Immunosuppressive drugs for kidney transplantation. N. Engl. J. Med. 351: 2715-2729.
2. Kriegel, N. R., and S. Emre. 2004. Novel immunosuppressants. Pediatr. Transplantation 8: 594-599.
3. Liu, J., J. D. Farmer, W. S. Lane, Jr., J. Friedman, I. Weissman, and S. L. Schreiber. 1991. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66: 807-815.
4. Luo, C., E. Burgeon, J. A. Carew, P. G. McCaffrey, T. M. Badalian, W. S. Lane, P. G. Hogan, and A. Rao. 1996. Recombinant NFAT1 (NFATp) is regulated by calcineurin in T cells and mediates transcription of several cytokine genes. Mol. Cell. Biol. 16: 3955-3966.
5. Fischer, G., B. Wittmann-Liebold, K. Lang, T. Kiefhaber, and F. X. Schmid. 1989. Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins. Nature 337: 476-478.
6. Harding, M. W., A. Galat, D. E. Uehling, and S. L. Schreiber. 1989. A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. Nature 341: 758-760.
7. Sikierka, J. J., S. H. Hung, M. Poe, C. S. Lin, and N. H. Sigal. 1989. A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin. Nature 341: 755-757.
8. Takahashi, N., T. Hayano, and M. Suzuki. 1989. Peptidyl-propyl cis-trans isomerase is the cyclosporine A-binding protein. Nature 337: 473-475.
9. Yaffe, M. B., M. Schutkowski, M. Shen, X. Z. Zhou, P. T. Stukenberg, J. U. Rahfeld, J. Xu, J. Kuang, M. W. Kirschner, G. Fischer, et al. 1997. Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism. Science 278: 1957-1960.
10. Ranganathan, R., K. P. Lu, T. Hunter, and J. P. Noel. 1997. Structural and functional analysis of the mitotic rotamase Pin1 suggests substrate recognition is phosphorylation dependent. Cell 89: 875-886.
11. Lu, K. P., S. D. Hanes, and T. Hunter. 1996. A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature 380: 544-547.
12. Verdecia, M. A., M. E. Bowman, K. P. Lu, T. Hunter, and J. P. Noel. 2000. Structural basis for phosphoserine-proline recognition by group IV WW domains. Nat. Struct. Biol. 7: 639-643.
13. Lu, P. J., G. Wulf, X. Z. Zhou, P. Davies, and K. P. Lu. 1999. The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated τ protein. Nature 399: 784-788.
14. Ryo, A., M. Nakamura, G. Wulf, Y. C. Liou, and K. P. Lu. 2001. Pin1 regulates turnover and subcellular localization of β-catenin by inhibiting its interaction with APC. Nat. Cell. Biol. 9: 793-801.
15. Ryo, A., F. Suizu, Y. Yoshida, K. Perrem, Y. C. Liou, G. Wulf, R. Rottapel, S. Yamaoka, and K. P. Lu. 2003. Regulation of NF-κB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. Mol. Cell 12: 1413-1426.
16. Lu, P. J., X. Z. Zhou, C. Liou, J. P. Noel, and K. P. Lu. 2002. Critical role of WW domain phosphorylation in regulating phosphoserine binding activity and Pin1 function. J. Biol. Chem. 277: 2381-2384.
17. Liou, Y. C., A. Ryo, H. K. Huang, P. J. Lu, R. Bronson, F. Fujimori, T. Uchida, T. Hunter, and K. P. Lu. 2002. Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes. Proc. Natl. Acad. Sci. USA 99: 1335-1340.
18. Wulf, G. M., A. Ryo, G. G. Wulf, S. W. Lee, T. Niu, V. Petkova, and K. P. Lu. 2001. Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1. EMBO J. 20: 3459-3472.
19. Ayala, G., D. Wang, G. Wulf, A. Frolov, R. Li, J. Sowadski, T. M. Wheeler, K. P. Lu, and L. Bao. 2003. The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer. Cancer Res. 63: 6244-6251.
20. Liou, Y. C., A. Sun, A. Ryo, X. Z. Zhou, Z. X. Yu, H. K. Huang, T. Uchida, R. Bronson, G. Bing, X. Li, et al. 2003. Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration. Nature 424: 556-561.
21. Pastorino, L., A. Sun, P. J. Lu, X. Z. Zhou, M. Balastik, G. Finn, G. Wulf, J. Lim, S. H. Li, X. Li, et al. 2006. The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-β production. Nature 440: 528-534.
22. Shen, Z. J., S. Esnault, and J. S. Malter. 2005. Pin1 regulates GM-CSF mRNA stability in activated eosinophils. Nat. Immunol. 6: 1280-1287.
23. Esnault, S., and J. S. Malter. 2003. Hyaluronic acid or TNF-α plus fibronectin triggers granulocyte macrophage-colony-stimulating factor mRNA stabilization in eosinophils yet engages differential intracellular pathways and mRNA binding proteins. J. Immunol. 171: 6780-6787.
24. Xing, Z., Y. Ohkawara, M. Jordana, F. Graham, and J. Gauldie. 1996. Transfer of granulocyte-macrophage colony-stimulating factor gene to rat lung induces eosinophilia, monocytosis, and fibrotic reactions. J. Clin. Invest. 97: 1102-1110.
25. Lindstein, T., C. H. June, J. A. Ledbetter, G. Stella, and C. B. Thompson. 1989. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 244: 339-343.
26. Bickel, M., R. B. Cohen, and D. H. Pluznik. 1990. Post-transcriptional regulation of granulocyte-macrophage colony-stimulating factor synthesis in murine T cells. J. Immunol. 145: 840-845.
27. Capowski, E. E., S. Esnault, S. Bhattacharya, and J. S. Malter. 2001. Y box-binding factor promotes eosinophil survival by stabilizing granulocyte-macrophage colony-stimulating factor mRNA. J. Immunol. 167: 5970-5976.
28. Janowski, B., S. Wollner, M. Schutkowski, and G. Fischer. 1997. A protease-free assay for peptidyl prolylcis/trans isomerases using standard peptide substrates. Anal. Biochem. 252: 299-307.
29. Hennig, L., C. Christner, M. Kipping, B. Schelbert, K. P. Rucknagel, S. Grabley, G. Kullertz, and G. Fischer. 1998. Selective inactivation of parvulin-like peptidyl-prolyl cis/trans isomerases by juglone. Biochemistry 37: 5953-5960.
30. Kelly, E. A. B., R. R. Rodriguez, W. W. Busse, and N. N. Jarjour. 1997. The effect of segmental bronchoprovocation with allergen on airway lymphocyte function. Am. J. Respir. Crit. Care Med. 156: 1421-1428.
31. Ramesh, K. S., R. E. Rocklin, and S. H. Pincus. 1987. Phosphorylation and dephosphorylation of soluble proteins in human eosinophils. J. Cell. Biochem. 34: 203-211.
32. Hall, D. J., J. Cui, M. E. Bates, B. A. Stout, L. Koenderman, P. J. Coffer, and P. J. Bertics. 2001. Transduction of a dominant-negative H-Ras into human eosinophils attenuates extracellular signal-regulated kinase activation and interleukin-5-mediated cell viability. Blood 98: 2014-2021.
33. Vocero-Akbani, A., N. A. Lissy, and S. F. Dowdy. 2000. Transduction of full-length Tat fusion proteins directly into mammalian cells: analysis of T cell receptor activation-induced cell death. Methods Enzymol. 322: 508-521.
34. Esnault, S., and J. S. Malter. 2001. Granulocyte macrophage-colony- stimulating factor mRNA is stabilized in airway eosinophils and peripheral blood eosinophils activated by TNF-α plus fibronectin. J. Immunol. 166: 4658-4663.
35. Stoecklin, G., P. Stoeckle, M. Lu, O. Muehlemann, and C. Moroni. 2001. Cellular mutants define a common mRNA degradation pathway targeting cytokine AU-rich elements. RNA 7: 1578-1588.
36. Sullivan, D. E., M. Ferris, D. Pociask, and A. R. Brody. 2005. Tumor necrosis factor-α induces transforming growth factor-β1 expression in lung fibroblasts through the extracellular signal-regulated kinase pathway. Am. J. Respir. Cell Mol. Biol. 32: 342-349.
37. Carballo, E., W. S. Lai, and P. J. Blackshear. 2000. Evidence that tristetraprolin is a physiological regulator of granulocyte-macrophage colony-stimulating factor messenger RNA deadenylation and stability. Blood 95: 1891-1899.
38. Fan, X. C., and J. A. Steitz. 1998. Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs. EMBO J. 17: 3448-3460.
39. Loflin, P., C. Y. Chen, and A. B. Shyun. 1999. Unraveling a cytoplasmic role for hnRNP D in the in vivo mRNA destabilization directed by the AU-rich element. Genes Dev. 13: 1884-1897.
40. Sarkar, B., Q. Xi, C. He, and R. J. Schneider. 2003. Selective degradation of AU-rich mRNAs promoted by the p37 AUF1 protein isoform. Mol. Cell Biol. 23: 6685-6693.
41. Xu, N., C. Y. Chen, and A. B. Shyu. 2001. Versatile role for hnRNP D isoforms in the differential regulation of cytoplasmic mRNA turnover. Mol. Cell. Biol. 21: 6960-6971.
42. Wilson, G. M., J. Lu, K. Sutphen, Y. Suarez, S. Sinha, B. Brewer, E. C. Villanueva-Feliciano, R. M. Ysla, S. Charles, and G. Brewer. 2003. Phosphorylation of p40AUF1 regulates binding to A + U-rich mRNA-destabilizing elements and protein-induced changes in ribonucleoprotein structure. J. Biol. Chem. 278: 33039-33048.
43. Lal, A., K. Mazan-Mamczarz, T. Kawai, X. Yang, J. L. Martindale, and M. Gorospe. 2004. Concurrent versus individual binding of HuR and AUF1 to common labile target mRNAs. EMBO J. 23: 3092-3102.
44. DeMaria, C. T., and G. Brewer. 1996. AUF1 binding affinity to A + U-rich elements correlates with rapid mRNA degradation. J. Biol. Chem. 271: 12179-12184.
45. Levy, N. S., S. Chung, H. Furneaux, and A. P. Levy. 1998. Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR. J. Biol. Chem. 273: 6417-6423.
46. Chen, C. Y., R. Gherzi, S. E. Ong, E. L. Chan, R. Raijmakers, G. J. Pruijn, G. Stoecklin, C. Moroni, M. Mann, and M. Karin. 2001. AU binding proteins recruit the exosome to degrade ARE-containing mRNAs. Cell 107: 451-464.
47. Tourriere, H., K. Chebli, and J. Tazi. 2002. mRNA degradation machines in eukaryotic cells. Biochimie 84: 821-837.
48. Kane, L. P., J. Lin, and A. Weiss. 2000. Signal transduction by the TCR for antigen. Curr. Opin. Immunol. 12: 242-249.
49. Dong, C., R. J. Davis, and R. A. Flavell. 2002. MAP kinases in the immune response. Annu. Rev. Immunol. 20: 55-72.
50. Chao, S. H., A. L. Greenleaf, and D. H. Price. 2001. Juglone, an inhibitor of the peptidyl-prolyl isomerase Pin1, also directly blocks transcription. Nucleic Acids Res. 29: 767-773.
51. Liu, W., H. D. Youn, X. Z. Zhou, K. P. Lu, and J. O. Liu. 2001. Binding and regulation of the transcription factor NFAT by the peptidyl prolyl cis-trans isomerase Pin1. FEBS Lett. 496: 105-108.
52. Inbaraj, J. J., and C. F. Chignell. 2004. Cytotoxic action of juglone and plumbagin: a mechanistic study using HaCaT keratinocytes. Chem. Res. Toxicol. 17: 55-62.
53. Decker, E. B., and A. Bonni. 2006. Pin1 mediates neural-specific activation of mitochondrial apoptotic machinery. Neuron 49: 655-662.
54. Lang, R. A., D. Metcalf, R. A. Cuthbertson, I. Lyons, E. Stanley, A. Kelso, G. Kannourakis, D. J. Williamson, G. K. Klintworth, T. J. Gonda, and A. R. Dunn. 1987. Transgenic mice expressing a hemopoietic growth factor gene (GM-CSF) develop accumulations of macrophages, blindness, and a fatal syndrome of tissue damage. Cell 51: 675-686.
55. Biondo, M., Z. Nasa, A. Marshall, B. H. Toh, and F. Alderuccio. 2001. Local transgenic expression of granulocyte macrophage-colony stimulating factor initiates autoimmunity. J. Immunol. 166: 2090-2099.
56. Johnson, G. R., T. J. Gonda, D. Metcalf, I. K. Hariharan, and S. Cory. 1989. A lethal myeloproliferative syndrome in mice transplanted with bone marrow cells infected with a retrovirus expressing granulocyte-macrophage colony stimulating factor. EMBO J. 8: 441-448.
57. He, J. Q., J. Ruan, M. Chan-Yeung, A. B. Becker, H. Dimich-Ward, P. D. Pare, and A. J. Sandford. 2003. Polymorphisms of the GM-CSF genes and the development of atopic diseases in at-risk children. Chest 123: 438S.
58. De Vries, E. G., B. Biesma, P. H. Willemse, N. H. Mulder, A. C. Stern, J. G. Aalders, and E. Vellenga. 1991. A double-blind placebo-controlled study with granulocyte-macrophage colony-stimulating factor during chemotherapy for ovarian carcinoma. Cancer Res. 51: 116-122.